Rethinking hyperbilirubinemia: Gilbert syndrome in children with cystic fibrosis, a case report.
Publication
, Journal Article
Salameh, Y; Lyles, J; Yousef, S
Published in: Respir Med Case Rep
2025
Cystic Fibrosis leads to liver complications, including cystic fibrosis liver disease but hyperbilirubinemia in CF patients on CFTR modulators is less understood. This article describes two pediatric CF patients on Elexacaftor/Tezacaftor/Ivacaftor therapy with elevated bilirubin, ultimately diagnosed with Gilbert syndrome, highlighting the importance of fractionated bilirubin testing for early diagnosis and management.
Duke Scholars
Published In
Respir Med Case Rep
DOI
ISSN
2213-0071
Publication Date
2025
Volume
58
Start / End Page
102340
Location
England
Related Subject Headings
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Salameh, Y., Lyles, J., & Yousef, S. (2025). Rethinking hyperbilirubinemia: Gilbert syndrome in children with cystic fibrosis, a case report. Respir Med Case Rep, 58, 102340. https://doi.org/10.1016/j.rmcr.2025.102340
Salameh, Yara, John Lyles, and Shatha Yousef. “Rethinking hyperbilirubinemia: Gilbert syndrome in children with cystic fibrosis, a case report.” Respir Med Case Rep 58 (2025): 102340. https://doi.org/10.1016/j.rmcr.2025.102340.
Salameh Y, Lyles J, Yousef S. Rethinking hyperbilirubinemia: Gilbert syndrome in children with cystic fibrosis, a case report. Respir Med Case Rep. 2025;58:102340.
Salameh, Yara, et al. “Rethinking hyperbilirubinemia: Gilbert syndrome in children with cystic fibrosis, a case report.” Respir Med Case Rep, vol. 58, 2025, p. 102340. Pubmed, doi:10.1016/j.rmcr.2025.102340.
Salameh Y, Lyles J, Yousef S. Rethinking hyperbilirubinemia: Gilbert syndrome in children with cystic fibrosis, a case report. Respir Med Case Rep. 2025;58:102340.
Published In
Respir Med Case Rep
DOI
ISSN
2213-0071
Publication Date
2025
Volume
58
Start / End Page
102340
Location
England
Related Subject Headings
- 3201 Cardiovascular medicine and haematology